Table 3.
Study Measures at baseline and at the end point
| Variables |
Omega 3 |
P* |
Placebo |
P* |
Group effect comparison |
|||
|---|---|---|---|---|---|---|---|---|
|
Baseline |
End point |
Baseline |
End point |
F |
P** |
|||
| Mean(SD) | Mean(SD) | Mean(SD) | Mean(SD) | |||||
| BW† (kg) |
70.68 ± 13.35 |
75.03 ± 13.98 |
0 < 001 |
74.27 ± 11.17 |
78.35 ± 14.55 |
0.008 |
0.025 |
0.875 |
| BMI (kg/m2) |
24.43 ± 3.03 |
25.95 ± 3.27 |
0 < 001 |
24.95 ± 3.63 |
26.28 ± 4.66 |
0.004 |
0.137 |
0.714 |
| WC (cm) |
83.59 ± 8.88 |
86.84 ± 8.94 |
0.007 |
88.13 ± 13.23 |
91.02 ± 13.48 |
0.003 |
0.071 |
0.791 |
| SBP (mmHg) |
119.50 ± 9.98 |
115.50 ± 11.45 |
0.088 |
113.80 ± 9.34 |
115.50 ± 8.21 |
0.560 |
3.011 |
0.091 |
| TC (mg/dl) |
172.30 ± 34.94 |
187.90 ± 34.55 |
0.023 |
177.66 ± 37.78 |
206.09 ± 52.71 |
0.001 |
1.69 |
0.201 |
| LDL (mg/dl) |
86.40 ± 22.16 |
100.30 ± 17.93 |
0.004 |
91.09 ± 24.49 |
104.14 ± 30.78 |
0.004 |
0.021 |
0.885 |
| HDL (mg/dl) |
35.45 ± 9.04 |
35.45 ± 8.78 |
1.000 |
37.23 ± 11.30 |
39.23 ± 10.21 |
0.021 |
0.868 |
0.357 |
| Non-HDL-C (mg/dl) |
136.85 ± 30.63 |
152.45 ± 30.29 |
0.013 |
141.28 ± 34.73 |
166.85 ± 50.83 |
0.001 |
1.387 |
0.246 |
| TG (mg/dl) |
162.90 ± 72.51 |
165.95 ± 68.79 |
0.825 |
168.90 ± 71.83 |
171.76 ± 88.54 |
0.865 |
0.000 |
0.993 |
| Lipo (a) (mg/dl) |
46.64 ± 43.52 |
43.85 ± 29.81 |
0.623 |
45.35 ± 38.21 |
65.47 ± 57.52 |
0.042 |
4.507 |
0.040 |
| Fibrinigen (mg/dl) |
321.95 ± 56.41 |
283.80 ± 71.62 |
0.041 |
286.23 ± 47.34 |
282.57 ± 63.83 |
0.787 |
2.497 |
0.122 |
| CRP-hs (mg/dl) | 4.33 ± 4.198 | 4.11 ± 8.46 | 0.969 | 3.10 ± 3.17 | 3.49 ± 3.03 | 0.634 | 0.017 | 0.897 |
† BW, body weight; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; TC, total cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; Non-HDL-C, non high-density lipoprotein-cholesterol; TG, triglyceride; Lipo (a), lipoprotein Lp(a); CRP-hs, c-reactive protein, high sensitivity.
* P-values are given for the comparison of before-after changes in each group using paired-samples t test.
** P-values are given for comparison of end point changes from baseline using within-subjects effects of Repeated Measure ANOVA considering interaction of groups.